Merial has launched Equioxx, a new pain management product which the company says is the first COX-2 specific NSAID for horses
Traditional NSAIDs act by blocking the action of both COX-1 and COX-2 enzymes at the same time. Although COX-2 produces prostaglandins…
Merial - maker of the canine NSAID Previcox - has launched a campaign to raise awareness of the prevalence of canine osteoarthritis amongst dog owners in the UK.
Previcox Product Manager Claire Edmunds said: "We know that approximately 20% of adult dogs…
Merial has launched Supleneo flex, a nutraceutical supplement designed to be part of a Total Joint Health programme for dogs, administered once daily.
Merial says the new product supports its market position as a leading force in canine pain management,